NVIDIA Launches UK’s Most Powerful Supercomputer, for Research in AI and Healthcare
About NVIDIA
NVIDIA’s (NASDAQ: NVDA) invention of the GPU in 1999 sparked the growth of the PC gaming market and has redefined modern computer graphics, high performance computing and artificial intelligence. The company’s pioneering work in accelerated computing and AI is reshaping trillion-dollar industries, such as transportation, healthcare and manufacturing, and fueling the growth of many others. More information at https://nvidianews.nvidia.com/.
Certain statements in this press release including, but not limited to, statements as to: the benefits, impact, performance, features, and availability of our products and services; Cambridge-1 enabling top scientists and healthcare experts to accelerate the digital biology revolution and bolster the U.K.’s world-leading life sciences industry; the details and impact of NVIDIA’s collaborations with partners including AstraZeneca, GSK, Guy’s and St Thomas’ NHS Foundation Trust, King’s College London, and Oxford Nanopore; Cambridge-1’s potential economic value created; the AI synthetic brain model taught by Cambridge-1 allowing a better and more nuanced understanding of what diseases look like, possibly enabling an earlier and more accurate diagnosis; King’s College London’s intent to share synthetic data model with the greater research and startup community; transformer-based neural network architectures allowing researchers to leverage massive datasets; and access to Cambridge-1 contributing additional computational power and state-of-the-art AI technology to GSK’s drug discovery process are forward-looking statements that are subject to risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include: global economic conditions; our reliance on third parties to manufacture, assemble, package and test our products; the impact of technological development and competition; development of new products and technologies or enhancements to our existing product and technologies; market acceptance of our products or our partners' products; design, manufacturing or software defects; changes in consumer preferences or demands; changes in industry standards and interfaces; unexpected loss of performance of our products or technologies when integrated into systems; as well as other factors detailed from time to time in the most recent reports NVIDIA files with the Securities and Exchange Commission, or SEC, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. Copies of reports filed with the SEC are posted on the company's website and are available from NVIDIA without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, NVIDIA disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.
© 2021 NVIDIA Corporation. All rights reserved. NVIDIA, the NVIDIA logo, BlueField, DGX, NGC, NVIDIA Clara, and NVIDIA DGX SuperPOD are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries. All other trademarks and copyrights are the property of their respective owners. Features, pricing, availability and specifications are subject to change without notice.